SCHEMBL8659693

SCHEMBL8659693

CCOC(=O)Cc1cnc(C#Cc2cc3c(cc2C)OCCC3(CC)CC)cn1

nearest known ligand 0.32

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
CYP3A4 P08684 1/20 0.32
RARA P10276 1/20 0.32
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
KMT2A Q03164 1/20 0.32
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8661225 0.92 ALDH1A1 (0.33) NPC1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL7648986 0.90
SCHEMBL7652976 0.89 TBXAS1 (0.30) NPC1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL8659451 0.87 PTGDR2 (0.31)
SCHEMBL8663224 0.87 CYP3A4 (0.36) NPC1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL8659868 0.86 CYP3A4 (0.32) NPC1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL8659621 0.86 CYP3A4 (0.42) NPC1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL8661136 0.84 SMN1; SMN2 (0.33) NPC1MAPTRAB9ASMN1; SMN2NPSR1
SCHEMBL8658232 0.83 CYP3A4 (0.41) SMN1; SMN2CYP3A4RARARARBRARG
SCHEMBL7653651 0.82 CYP3A4 (0.35) NPC1MAPTRAB9ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5750693-A THIOCHROMANYL OR CHROMANYL COMPOUNDS AS ANTICARCINOGINIC AGENTS, SKIN DISORDERS AND ATHEROSCLEROSIS ALLERGAN (US) 1998-05-12 US disclosed
US-5677451-A CONTROLLING CELL DIFFERENTIATION; SKIN DISORDERS; ANTICANCER AGENTS ALLERGAN (US) 1997-10-14 US disclosed